Difei Yang

Work

Analyst Difei Yang works at MIZUHO and is focused on the Healthcare sector with 384 price targets and ratings documented since 2015 spanning on 24 stocks. Analyst's average stock valuation to be materialised ratio is 48.66% with an average time for price targets to be met of 185.55 days.

Most recent stock forecast was given on SRPT, Sarepta Therapeutics, Inc at 24-Jun-2022.

Difei Yang best performing recommendations are on RLYP.
The best stock recommendation documented was for RLYP at 7/18/2016. The price target of $26 was fulfilled within 3 days with a profit of $5.75 (28.4%) receiving and performance score of 94.65.

Average potential price target upside

AERI AKBA BLUE CNCE FGEN FRLN HZNP MNTA NKTR NVCR RLYP RVNC SELB SRPT XERS ZGNX MGTA ONCE PTX AVRO HRTX ALDR BOLD EOLS
AERI AKBA BLUE CNCE FGEN FRLN HZNP MNTA NKTR NVCR RLYP RVNC SELB SRPT XERS ZGNX MGTA ONCE PTX AVRO HRTX ALDR BOLD EOLS